- cafead   Jul 20, 2022 at 10:03: AM
via A Texas federal court has determined that Daiichi Sankyo willfully infringed a Seagen patent in creating its breast cancer drug Enhertu. But it will not enhance a $41.8 million award resulting from a jury trial in April.
article source
article source